Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
ES01 - What Is the Role of Chemotherapy in the Era of Immunotherapy in Advanced NSCLC?
- 10:30 - 12:00
- 9/08/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Educational Session
- Track: Advanced NSCLC
- Moderators:Oscar Gerardo Arrieta, Reyes Bernabe
-
+
ES01.05 - Future of Dual Anti-CTLA4 and PD1/PDL1 Blockade
11:30 - 11:45 | Presenter: David R Spigel
- Abstract
No abstract available for this presentation
-
+
MA07 - Clinical Questions and Potential Blood Markers for Immunotherapy
- 13:30 - 15:00
- 9/08/2019
- Location: Vancouver (2003)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Immuno-oncology
- Moderators:David R Spigel, Roberto Ferrara
-
+
MA07.01 - Circulating Immature Neutrophils, Tumor-Associated Neutrophils and dNLR for Identification of Fast Progressors to Immunotherapy in NSCLC
13:30 - 13:35 | Presenter: Laura Mezquita | Author(s): Patricia Martin-Romano, Edouard Auclin, Boris Duchemann, Lydie Cassard, David Planchard, Marie Naigeon, Ithar Gataa, Melinda Charrier, Roberto Ferrara, Lisa Boselli, Jonathan Grivel, Maud Ngocamus, Julien Adam, Nathalie Chaput, Benjamin Besse
- Abstract
Loading... -
+
MA07.02 - Early Change of dNLR Is Correlated with Outcomes in Advanced NSCLC Patients Treated with Immunotherapy
13:35 - 13:40 | Presenter: Laura Mezquita | Author(s): Isabel Preeshagul, Edouard Auclin, Diana Saravia, Lizza Hendriks, Hira Rizvi, David Planchard, Wungki Park, Ernest Nadal, Jose Carlos Ruffinelli, Santiago Ponce, Clarisse Audigier-Valette, Simona Carnio, Silvia Novello, Gerard Zalcman, Margarita Majem, Annapaola Mariniello, Anne Marie Clasina Dingemans, Gilberto Lopes, Caroline Rossoni, Jean-Pierre Pignon, Nathalie Chaput, Matthew Hellmann, Kathryn C. Arbour, Benjamin Besse
- Abstract
Loading... -
+
MA07.03 - A Circulating MicroRNAs-Based Test as Biomarker of Primary and Secondary Resistance in PD-L1 ≥50% NSCLC Treated with Immunotherapy
13:40 - 13:45 | Presenter: Claudia Proto | Author(s): Arsela Prelaj, Carla Verri, Diego Signorelli, Giuseppe Lo Russo, Roberto Ferrara, Giulia Galli, Benedetta Trevisan, Mavis Mensah, Filippo Guglielmo Maria De Braud, Marina Chiara Garassino, Gabriella Sozzi, Mattia Boeri
- Abstract
Loading... -
+
MA07.04 - Discussant - MA07.01, MA07.02, MA07.03
13:45 - 14:00 | Presenter: Sara Pilotto
- Abstract
No abstract available for this presentation
-
+
MA07.05 - Immune Checkpoint Inhibitor (ICPi) Re-Challenge: Outcomes Analysis in a French National Cohort of Non-Small-Cell Lung Cancer (NSCLC) Patients
14:00 - 14:05 | Presenter: Elisa Gobbini | Author(s): Anne Claire Toffart, Maurice Perol, Jean-Baptiste Assié, Michael Duruisseaux, Dahna Coupez, Radj Gervais, Virginie Westeel, Myriam Delaunay, Florian Guisier, Remi Veillon, Valérie Gounant, Etienne Giroux Leprieur, François Roger Vanel, Nouha Chaabane, Eric Dansin, Hélène Babey, Chantal Decroisette, Fabrice Barlesi, Nicolas Girard, Pierre Fournel, Laura Mezquita, Youssef Oulkhouir, Anthony Canellas, Boris Duchemann, Olivier Molinier, Denis Moro-Sibilot, Matteo Giaj Levra
- Abstract
Loading... -
+
MA07.06 - Immunotherapy Re-Challenge After Nivolumab Treatment in Advanced Non-Small Cell Lung Cancer in French Real-World Setting
14:05 - 14:10 | Presenter: Matteo Giaj Levra | Author(s): François-Emery Cotté, Romain Corre, Christophe Calvet, Baptiste Jouaneton, Ronan Jolivel, Anne-Françoise Gaudin, Valentine Grumberg, Jean-Baptiste Assié, Christos Chouaid
- Abstract
Loading... -
+
MA07.07 - Discussant - MA07.05, MA07.06
14:10 - 14:25 | Presenter: Helena Linardou
- Abstract
No abstract available for this presentation
-
+
MA07.08 - The Role of a Cachexia Grading System in Patients with NSCLC Treated with Immunotherapy: Implications for Response and Survival
14:25 - 14:30 | Presenter: Jenny Georgina Turcott | Author(s): Andrés Felipe Cardona, Laura Alejandra Ramírez-Tirado, Zyanya Lucia Zatarain Barrón, Feliciano Barrón, Luis Corrales, Claudio Martin, Pablo Alan Barragán Castillo, Diana Flores-Estrada, Alejandro Ruiz-Patiño, Oscar Gerardo Arrieta
- Abstract
Loading... -
+
MA07.09 - Impact of Body Mass Index on Clinical Outcomes of Immune Checkpoint Blockers in Advanced Non-Small Cell Lung Cancer
14:30 - 14:35 | Presenter: Amit Arun Kulkarni | Author(s): Shijia Zhang, Todd De For, Manish Patel
- Abstract
Loading... -
+
MA07.10 - The Influence of Sex on Immunotherapy Efficacy in Non-Small Cell Lung Cancer
14:35 - 14:40 | Presenter: Stephanie Tuminello | Author(s): Rajwanth Veluswamy, Naomi Alpert, John Lazar, Raja Flores, Maaike Van Gerwen
- Abstract
Loading... -
+
MA07.11 - Survival Outcomes Based on Gender of Advanced Nonsmall Cell Lung Cancer Patients Treated with Pembrolizumab or Nivolumab in Everyday Clinical Practice
14:40 - 14:45 | Presenter: Doran Ksienski | Author(s): Elaine S Wai, Nicole Croteau, Ashley T. Freeman, Leathia Fiorino, Angela Chan, Dave Fenton, Georgia Geller, Edward Brooks, Zia Poonja, Sarah Irons, Mary Lesperance
- Abstract
Loading... -
+
MA07.12 - Discussant - MA07.08, MA07.09, MA07.10, MA07.11
14:45 - 15:00 | Presenter: Sonja Loges
- Abstract
No abstract available for this presentation
-
+
OA03 - Systemic Therapies for SCLC: Novel Targets and Patients' Selection
- 13:30 - 15:00
- 9/08/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Oral Session
- Track: Small Cell Lung Cancer/NET
- Moderators:Christine Lee Hann, Makoto Nishio
-
+
OA03.03 - Initial Efficacy and Safety Results of Irinotecan Liposome Injection (nal-IRI) in Patients with Small Cell Lung Cancer
13:50 - 14:00 | Presenter: Luis Paz-Ares | Author(s): David R Spigel, Yuanbin Chen, Maria Jove, Oscar Juan, Patricia Rich, Theresa Hayes, Vanesa Gutiérrez Calderón, Reyes Bernabe, Alejandro Navarro, Afshin Dowlati, Bin Zhang, Yan Moore, Tiffany Wang, Natalya Nazarenko, Santiago Ponce, Paul A Bunn, Jr
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P1.01-110 - Novel Regimens Versus Standard-of-Care in NSCLC: A Phase II, Randomized, Open-Label, Platform Trial Using a Master Protocol
09:45 - 09:45 | Presenter: David R Spigel | Author(s): Marina Chiara Garassino, Benjamin Besse, Adrian Sacher, Minal Barve, Sophie Cousin, Michael Schenker, Debra Rogan, Sapna Yadavilli, Andre Acusta, Ohad Amit, Ann Leighton-Swayze, Marc Ballas, Axel Hoos, Martin Reck, Sara Brett
- Abstract
Loading...
-
+
MA13 - Going Back to the Roots!
- 14:00 - 15:30
- 9/09/2019
- Location: Vancouver (2003)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Advanced NSCLC
- Moderators:Maurice Perol, Kaoru Kubota
-
+
MA13.05 - Nab-Paclitaxel Maintenance in Squamous Non-Small Cell Lung Cancer (NSCLC): Updated Results of the Phase III ABOUND.sqm Study
14:30 - 14:35 | Presenter: David R Spigel | Author(s): Robert M Jotte, Santiago Ponce Aix, Laurent Gressot, Daniel Morgensztern, Michael McCleod, Mark A Socinski, Davey Daniel, Oscar Juan, Kathryn F Mileham, HOWARD WEST, Ray Page, Niels Reinmuth, Jeanna Knoble, Olivia Yu Tian, Rafia Bhore, Marianne Wolfsteiner, Teng Jin Ong, Cesare Gridelli, Michael Thomas
- Abstract
Loading...
-
+
P2.01 - Advanced NSCLC
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P2.01-02 - CANOPY-A: A Phase 3 Study of Canakinumab as Adjuvant Therapy in Patients with Surgically Resected NSCLC
10:15 - 10:15 | Presenter: Edward Garon | Author(s): Andrea Ardizzoni, Fabrice Barlesi, Byoung Chul Cho, Pedro De Marchi, Yasushi Goto, Shun Lu, Luis Paz-Ares, David R Spigel, Michael Thomas, Bijoyesh Mookerjee, Pilar Cazorla Arratia, Jason Baum, Zhu Zewen, James Chih-Hsin Yang
- Abstract
Loading...
-
+
IS16 - Symposium by Novartis: The Road Ahead: New Horizons In The Treatment Of NSCLC (Not IASLC CME Accredited)
- 07:00 - 08:00
- 9/10/2019
- Location: Hilton Head (1978)
- Type: Industry Symposia & Workshops
- Track:
-
+
OA14 - Update of Phase 3 Trials and the Role of HPD
- 11:30 - 13:00
- 9/10/2019
- Location: Vienna (2016)
- IASLC CME Accredited
- Type: Oral Session
- Track: Immuno-oncology
- Moderators:Julie R Brahmer, Diego Signorelli
-
+
OA14.04 - Five-Year Outcomes From the Randomized, Phase 3 Trials CheckMate 017/057: Nivolumab vs Docetaxel in Previously Treated NSCLC
12:00 - 12:10 | Presenter: Scott Gettinger | Author(s): Hossein Borghaei, Julie R Brahmer, Laura QM Chow, Marco Angelo Burgio, Javier De Castro Carpeno, Adam Pluzanski, Oscar Arrieta, Osvaldo Aren Frontera, Rita Chiari, Charles A Butts, Joanna Wojcik-Tomaszewska, Bruno Coudert, Marina Chiara Garassino, Neal Ready, Enriqueta Felip, Miriam Alonso Garcia, David M Waterhouse, Manuel Dómine, Fabrice Barlesi, Scott J. Antonia, Markus Wohlleber, David E. Gerber, Grzegorz Czyzewicz, David R Spigel, Lucio Crino, Wilfried Ernst Erich Eberhardt, Ang Li, Sathiya Marimuthu, Everett E. Vokes
- Abstract
Loading...